News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Holdbrook Mark J.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/21/2023 |
4
| Holdbrook Mark J. (V.P., Clinical Affairs) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns:
| Sold 188 shares
@ $13.28, valued at
$2.5k
Sold 198 shares
@ $12.61, valued at
$2.5k
|
|
03/17/2023 |
4
| Holdbrook Mark J. (V.P., Clinical Affairs) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns:
| Sold 187 shares
@ $13.43, valued at
$2.5k
Exercised 2,653 restricted stock units
@ $0 |
|
03/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/15/2020 |
3
| Holdbrook Mark J. (V.P., Clinical Affairs) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
|
|